Leigh Syndrome Due to


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
09 11 2020
Historique:
received: 13 10 2020
revised: 02 11 2020
accepted: 07 11 2020
entrez: 13 11 2020
pubmed: 14 11 2020
medline: 27 7 2021
Statut: epublish

Résumé

Leigh syndrome (LS) is most frequently characterized by the presence of focal, bilateral, and symmetric brain lesions Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is a rare condition, characterized by progressive pyramidal, cerebellar, and dorsal column dysfunction. We describe a case with infantile-onset neurodegeneration, psychomotor retardation, irritability, hypotonia, and nystagmus. Brain MRI demonstrated signal abnormalities in the deep cerebral white matter, corticospinal and dorsal column tracts, and pyramids, which resemble the MRI pattern of a severe form of LBSL, and involvement of basal ganglia and thalamus that resemble the radiological features of LS. We identified biallelic loss-of-function mutations, one novel (c.756delC, p.Thr253Glnfs*44) and another reported (c.1156C > T, p.Arg386Cys), in

Identifiants

pubmed: 33182419
pii: genes11111325
doi: 10.3390/genes11111325
pmc: PMC7697158
pii:
doi:

Substances chimiques

NDUFV1 protein, human 0
Aspartate-tRNA Ligase EC 6.1.1.12
Electron Transport Complex I EC 7.1.1.2

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Ann Neurol. 2003 Feb;53(2):252-8
pubmed: 12557294
Front Neurol. 2018 Sep 13;9:724
pubmed: 30271374
AJNR Am J Neuroradiol. 2000 Sep;21(8):1502-9
pubmed: 11003287
Nat Genet. 1999 Mar;21(3):260-1
pubmed: 10080174
Ann Neurol. 1996 Mar;39(3):343-51
pubmed: 8602753
Clin Neuroradiol. 2018 Sep;28(3):451-453
pubmed: 29147736
Clin Genet. 2012 Sep;82(3):264-70
pubmed: 21696386
Clin Genet. 2011 Sep;80(3):293-6
pubmed: 21815884
Brain Dev. 2018 Jun;40(6):498-502
pubmed: 29506883
Pediatr Neurol. 2007 Jan;36(1):54-7
pubmed: 17162199
AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1119-37
pubmed: 8237691
J Child Neurol. 2013 Dec;28(12):1681-5
pubmed: 23143729
Metab Brain Dis. 2018 Jun;33(3):805-812
pubmed: 29359243
Pediatr Neurol. 2005 May;32(5):334-40
pubmed: 15866434
Indian J Pediatr. 2018 Dec;85(12):1128-1131
pubmed: 29948731
Pediatr Radiol. 2016 Apr;46(4):443-51
pubmed: 26739140
Mol Genet Metab. 2012 Feb;105(2):163-72
pubmed: 22142868
Neurogenetics. 2019 Mar;20(1):9-25
pubmed: 30607703
Arq Neuropsiquiatr. 2007 Jun;65(2B):506-11
pubmed: 17665025
BMC Neurol. 2018 Oct 23;18(1):175
pubmed: 30352563
Gene. 2013 Mar 1;516(1):162-7
pubmed: 23266820
Neuropediatrics. 2012 Dec;43(6):332-8
pubmed: 23065766
Mitochondrion. 2013 Nov;13(6):749-54
pubmed: 23562761
Brain. 2014 Apr;137(Pt 4):1019-29
pubmed: 24566671
Biochem J. 2013 Mar 1;450(2):345-50
pubmed: 23216004

Auteurs

Nurun Nahar Borna (NN)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.

Yoshihito Kishita (Y)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.

Norio Sakai (N)

Child Healthcare and Genetic Science Laboratory, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Yusuke Hamada (Y)

Department of Pediatrics, Toyonaka Municipal Hospital, Toyonaka, Osaka 560-8565, Japan.

Koji Kamagata (K)

Department of Radiology, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.

Masakazu Kohda (M)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.

Akira Ohtake (A)

Department of Pediatrics & Clinical Genomics, Faculty of Medicine, Saitama Medical University, Moroyama, Saitama 350-0495, Japan.
Center for Intractable Diseases, Saitama Medical University Hospital, Moroyama, Saitama 350-0495, Japan.

Kei Murayama (K)

Department of Metabolism, Chiba Children's Hospital, Midori-ku, Chiba 266-0007, Japan.

Yasushi Okazaki (Y)

Diagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo 113-8421, Japan.
Laboratory for Comprehensive Genomic Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH